Matches in SemOpenAlex for { <https://semopenalex.org/work/W625331329> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W625331329 abstract "Section I: Technologies Foreword A Greeting from the Editor PART 0: INTRODUCTION Therapeutic Antibodies - From Past to Future PART I: SELECTING AND SHAPING THE ANTIBODY MOLECULE Selection strategies I: Monoclonal Antibodies Selection strategies II: Antibody Phage Display Selection strategies III: Transgenic Mice Bioinformatic Tools for Antibody Engineering Molecular Engineering I: Humanization Molecular Engineering II: Affinity Maturation Molecular Engineering III: Fc Engineering PART II: THE WAY INTO THE CLINIC Production and Downstream Processing Pharmaceutical Formulation and Clinical Application Immunogenicity of Antibody Therapeutics Regulatory Considerations Intellectual Property Issues Section II: Emerging Developments PART III: BEYOND IGG: MODIFIED ANTIBODIES Immunoscintigraphy and Radioimmunotherapy Bispecific Antibodies Immunotoxins / Targeted RNases PART IV: EMERGING CONCEPTS Automation of Selection and Engineering Emerging Technologies for Antibody Selection Emerging Alternative Production Systems Non-Antibody Scaffolds Emerging Therapeutic Concepts I: ADEPT Emerging Therapeutic Concepts II: Nanotechnology Emerging Therapeutic Concepts III:Cell-bound antibodies Emerging Therapeutic Concepts IV:Anti-idiotypic Antibodies PART V: ONGOING CLINICAL STUDIES: Antibodies in Phase I/II/III: Cancer Therapy Antibodies in Phase I/II/III: Targeting TNF Section III: APPROVED THERAPEUTICS Adalimumab (Humira) Alemtuzumab (Mabcampath) Bevacizumab (Avastin) Cetuximab (Erbitux) Efalizumab (Raptiva) Fanolesomab/Technetium99m (Neutrospec) Gemtuzumab Ozogamicin (Mylotarg) Infliximab (Remicade) Muromonab (Orthoclone) Natalizumab (Tysabri) Omalizumab (Xolair) Palivizumab (Synagis) Rituximab (Rituxan) Trastuzumab (Herceptin) Overview: Abciximab, Arcitumomab, Basiliximab, Capromab, Cotara, Daclizumab, Edrecolomab, Igovomab, Nofetumomab, Satumomab, Sulesomab, Tositumomab and Votumumab Yttrium-90 Ibritumomab Tiuxetan (Zevalin)" @default.
- W625331329 created "2016-06-24" @default.
- W625331329 creator A5043280562 @default.
- W625331329 date "2010-01-01" @default.
- W625331329 modified "2023-09-24" @default.
- W625331329 title "Handbook of therapeutic antibodies : technologies, emerging developments and approved therapeutics" @default.
- W625331329 hasPublicationYear "2010" @default.
- W625331329 type Work @default.
- W625331329 sameAs 625331329 @default.
- W625331329 citedByCount "2" @default.
- W625331329 countsByYear W6253313292012 @default.
- W625331329 crossrefType "book" @default.
- W625331329 hasAuthorship W625331329A5043280562 @default.
- W625331329 hasConcept C10205521 @default.
- W625331329 hasConcept C141105273 @default.
- W625331329 hasConcept C159654299 @default.
- W625331329 hasConcept C176290653 @default.
- W625331329 hasConcept C203014093 @default.
- W625331329 hasConcept C2776146153 @default.
- W625331329 hasConcept C2777575956 @default.
- W625331329 hasConcept C2778515704 @default.
- W625331329 hasConcept C2778564945 @default.
- W625331329 hasConcept C2778623314 @default.
- W625331329 hasConcept C2779015954 @default.
- W625331329 hasConcept C2779719350 @default.
- W625331329 hasConcept C2780132546 @default.
- W625331329 hasConcept C28328180 @default.
- W625331329 hasConcept C502942594 @default.
- W625331329 hasConcept C542903549 @default.
- W625331329 hasConcept C54355233 @default.
- W625331329 hasConcept C71924100 @default.
- W625331329 hasConcept C86803240 @default.
- W625331329 hasConceptScore W625331329C10205521 @default.
- W625331329 hasConceptScore W625331329C141105273 @default.
- W625331329 hasConceptScore W625331329C159654299 @default.
- W625331329 hasConceptScore W625331329C176290653 @default.
- W625331329 hasConceptScore W625331329C203014093 @default.
- W625331329 hasConceptScore W625331329C2776146153 @default.
- W625331329 hasConceptScore W625331329C2777575956 @default.
- W625331329 hasConceptScore W625331329C2778515704 @default.
- W625331329 hasConceptScore W625331329C2778564945 @default.
- W625331329 hasConceptScore W625331329C2778623314 @default.
- W625331329 hasConceptScore W625331329C2779015954 @default.
- W625331329 hasConceptScore W625331329C2779719350 @default.
- W625331329 hasConceptScore W625331329C2780132546 @default.
- W625331329 hasConceptScore W625331329C28328180 @default.
- W625331329 hasConceptScore W625331329C502942594 @default.
- W625331329 hasConceptScore W625331329C542903549 @default.
- W625331329 hasConceptScore W625331329C54355233 @default.
- W625331329 hasConceptScore W625331329C71924100 @default.
- W625331329 hasConceptScore W625331329C86803240 @default.
- W625331329 hasLocation W6253313291 @default.
- W625331329 hasOpenAccess W625331329 @default.
- W625331329 hasPrimaryLocation W6253313291 @default.
- W625331329 hasRelatedWork W101392706 @default.
- W625331329 hasRelatedWork W1594700207 @default.
- W625331329 hasRelatedWork W1607133945 @default.
- W625331329 hasRelatedWork W1848910860 @default.
- W625331329 hasRelatedWork W1971242419 @default.
- W625331329 hasRelatedWork W2054383673 @default.
- W625331329 hasRelatedWork W2077748134 @default.
- W625331329 hasRelatedWork W2115122333 @default.
- W625331329 hasRelatedWork W2238650307 @default.
- W625331329 hasRelatedWork W2313408518 @default.
- W625331329 hasRelatedWork W2385804041 @default.
- W625331329 hasRelatedWork W2531906150 @default.
- W625331329 hasRelatedWork W2581362677 @default.
- W625331329 hasRelatedWork W3008694552 @default.
- W625331329 hasRelatedWork W3023704656 @default.
- W625331329 hasRelatedWork W3107318653 @default.
- W625331329 hasRelatedWork W316719949 @default.
- W625331329 hasRelatedWork W3186786458 @default.
- W625331329 hasRelatedWork W1974596630 @default.
- W625331329 hasRelatedWork W2481098068 @default.
- W625331329 isParatext "false" @default.
- W625331329 isRetracted "false" @default.
- W625331329 magId "625331329" @default.
- W625331329 workType "book" @default.